B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review

B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review

Abstract Background The advent of the immunomodulatory imide drugs (IMiDs) lenalidomide and thalidomide for the treatment of patients with plasma cell myeloma (PCM), has contributed to more than a doubling of the overall survival of these individuals. As a result, PCM patients join survivors of othe...

Full description

Bibliographic Details
Main Authors: Ryan B. Sinit, Dick G. Hwang, Prakash Vishnu, Jess F. Peterson, David M. Aboulafia
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Cancer
Subjects:
Myeloma
Lymphoblastic leukemia
Lenalidomide
Thalidomide
Therapy-related cancer
Online Access:http://link.springer.com/article/10.1186/s12885-019-6286-9

Internet

http://link.springer.com/article/10.1186/s12885-019-6286-9

Similar Items